China Modern Dairy (1117) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
28 Sep, 2026Executive summary
Revenue increased 8.6% year-over-year to RMB6,592.8 million in H1 2026, with net profit rebounding to RMB41.7 million from a loss of RMB983.8 million in H1 2025, driven by both raw milk and integrated dairy farming solutions.
Cash EBITDA rose 8.3% year-over-year to RMB1,598.8 million, and net cash from operating activities surged 56.8% to RMB768.5 million.
The acquisition of China Shengmu Organic Milk Limited (CSM) was completed, making the group the largest shareholder and expanding access to organic milk supply.
Strategic focus on digital services, overseas markets, and full industrial chain integration diversified profit drivers.
No interim dividend was declared for the period.
Financial highlights
Gross profit increased 7.7% year-over-year to RMB1,727.4 million, with gross margin stable at 26.2%.
Cash EBITDA grew 8.3% year-over-year to RMB1,598.8 million, with margin stable at 24.3%.
Feed costs per kg dropped 1.7% year-over-year, and overall COGS per kg fell 1.3%.
Financing cost rate reached a record low of 3.21%.
Cash and cash equivalents increased 20.6% to RMB95.4 million.
Outlook and guidance
Continued focus on digital transformation, smart animal husbandry, and expanding overseas markets.
Strategic synergies from the CSM acquisition are expected to drive scale, efficiency, and profitability.
Plans include expanding breeding R&D, forage and feed business, and digital platforms, while exploring international markets.
Ongoing cost control and efficiency improvements expected to support future profitability.
No interim dividend declared for the period.
Latest events from China Modern Dairy
- Gross margin and cash EBITDA margin rose as net loss narrowed despite lower revenue.1117
H2 2025 - Net loss widened on fair value losses despite record cash flow and milk production.1117
H1 2025 - Gross profit and cash EBITDA rose, but net profit turned negative due to non-cash impairments.1117
H2 2024 - Revenue fell 3.2% and cash EBITDA rose 19.2%, but net profit turned negative.1117
H1 2024